Chlorovinyls drive strong fourth quarter for Axiall
15:41 PM | February 14, 2013 | Clay Boswell
Axiall’s chlorovinyls segment posted operating income of $77 million for the quarter, up from $21.5 million in the year-ago period
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.